BRIEF published on 04/01/2026 at 07:35, 7 days 1 hour ago MaaT Pharma publishes data on aGvH in "Bone Marrow Transplantation" MaaT Pharma EMA AGvH Xervyteg® CHRONOS
BRIEF published on 04/01/2026 at 07:35, 7 days 1 hour ago MaaT Pharma Presents CHRONOS Study Results on Third-Line Acute GvHD MaaT Pharma Regulatory Review CHRONOS Study Acute GvHD Third-line Therapy
PRESS RELEASE published on 04/01/2026 at 07:30, 7 days 1 hour ago Inside Information / Other news releases MaaT Pharma announces publication of retrospective data from CHRONOS study in Bone Marrow Transplantation Journal, presenting real-world outcomes of third-line systemic treatments for GI-aGvHD patients MaaT Pharma GI-aGvHD CHRONOS Study Retrospective Data Bone Marrow Transplantation
BRIEF published on 03/31/2026 at 07:35, 8 days 1 hour ago MaaT Pharma: 2025 Revenue and Clinical Progress Revenue Funding Clinical Development MaaT Pharma Microbiothérapies
BRIEF published on 01/20/2026 at 18:35, 2 months 18 days ago MaaT Pharma Launches Phase 2 Trial for NSCLC Patients NSCLC MaaT Pharma Gut Microbiome IMMUNOLIFE Phase 2 Antibiotic-induced Dysbiosis
PRESS RELEASE published on 01/20/2026 at 18:30, 2 months 18 days ago Inside Information / Other news releases MaaT Pharma announces first patient randomized in IMMUNOLIFE Phase 2 study sponsored by Gustave Roussy to explore the role of gut microbiome in overcoming ICI resistance in NSCLC patients with antibiotic-induced dysbiosis NSCLC MaaT Pharma Gut Microbiome Antibiotic-induced Dysbiosis IMMUNOLIFE
BRIEF published on 12/10/2025 at 11:30, 3 months 28 days ago MaaT Pharma SACA Maintains Positive Outlook as Phase 3 Trial Data Strengthens Buy Recommendation Phase 3 Trial MaaT Pharma Xervyteg GI-aGvHD
PRESS RELEASE published on 12/10/2025 at 11:25, 3 months 28 days ago Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research updates recommendation to BUY for MaaT Pharma SACA with a target price of €17 following positive phase 3 trial results for Xervyteg presented at ASH Annual Meeting 2025 First Berlin Equity Research Buy Recommendation ASH Annual Meeting Xervyteg MaaT Pharma SACA
BRIEF published on 11/21/2025 at 11:27, 4 months 16 days ago Crossing Thresholds at MAAT PHARMA Voting Rights Capital Increase Crossing Thresholds MaaT Pharma Invus Public Equities
BRIEF published on 11/19/2025 at 11:16, 4 months 18 days ago MaaT Pharma Secures Capital to Support Commercialization Efforts Capital Increase MaaT Pharma Biotech Investment Xervyteg AGvHD Treatment
Published on 04/08/2026 at 08:05, 1 hour 7 minutes ago Tocvan Announces Addition of Second Drill Rig and Accelerates High-Priority Drill Targets at Flagship Gran Pilar Gold-Silver Project
Published on 04/08/2026 at 02:50, 6 hours 22 minutes ago Panther Minerals Announces Appointment of Rick Mah to Board of Directors
Published on 04/08/2026 at 01:35, 7 hours 37 minutes ago Polaris Renewable Energy Announces Q1 2026 Investor Call Details
Published on 04/08/2026 at 00:40, 8 hours 32 minutes ago Relevant Gold Announces Initial Closing of Strategic Financing
Published on 04/08/2026 at 00:10, 9 hours 2 minutes ago Trans Canada Gold Completes the Acquisition of the Harrison Lake District Scale Gold Property and First Tranche of the Non-Brokered Private Placement
Published on 04/08/2026 at 09:05, 7 minutes ago Lenzing Commissions 14 MW Power‑to‑Heat Facility, Strengthening Grid Stability and Heat Management
Published on 04/08/2026 at 09:00, 11 minutes ago Original-Research: EPH Group AG (von NuWays AG): BUY
Published on 04/08/2026 at 09:00, 11 minutes ago Original-Research: ASMALLWORLD AG (von NuWays AG): BUY
Published on 04/08/2026 at 08:30, 42 minutes ago Edenred Mobility and Electra form a strategic partnership to accelerate the electrification of commercial fleets in France
Published on 04/07/2026 at 17:57, 15 hours 14 minutes ago Peugeot Invest publishes its 2025 Universal Registration Document
Published on 04/07/2026 at 17:45, 15 hours 27 minutes ago ENGIE accelerates the deployment of battery storage with nearly 400 MW of new projects in Europe
Published on 04/07/2026 at 17:38, 15 hours 33 minutes ago Reporting on share buyback transactions carried out between March 30 and April 2, 2026
